Cargando…

Hepatitis C elimination: challenges with under-diagnosis and under-treatment

Hepatitis C infection has affected 189 million people globally and more than 4 million in the US. Owing to remarkable advances in the therapeutic sphere, essentially all infected patients can be expected to achieve cure. This provides an unprecedented opportunity to eliminate the risk of complicatio...

Descripción completa

Detalles Bibliográficos
Autor principal: Terrault, Norah A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6338244/
https://www.ncbi.nlm.nih.gov/pubmed/30687501
http://dx.doi.org/10.12688/f1000research.15892.1
_version_ 1783388426631905280
author Terrault, Norah A
author_facet Terrault, Norah A
author_sort Terrault, Norah A
collection PubMed
description Hepatitis C infection has affected 189 million people globally and more than 4 million in the US. Owing to remarkable advances in the therapeutic sphere, essentially all infected patients can be expected to achieve cure. This provides an unprecedented opportunity to eliminate the risk of complications from hepatitis C and to reduce the spread of the virus to others. To achieve this, a streamlined cascade of care from diagnosis to treatment may be enacted. Although great strides have been made, under-diagnosis and under-treatment remain major hurdles.
format Online
Article
Text
id pubmed-6338244
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher F1000 Research Limited
record_format MEDLINE/PubMed
spelling pubmed-63382442019-01-24 Hepatitis C elimination: challenges with under-diagnosis and under-treatment Terrault, Norah A F1000Res Review Hepatitis C infection has affected 189 million people globally and more than 4 million in the US. Owing to remarkable advances in the therapeutic sphere, essentially all infected patients can be expected to achieve cure. This provides an unprecedented opportunity to eliminate the risk of complications from hepatitis C and to reduce the spread of the virus to others. To achieve this, a streamlined cascade of care from diagnosis to treatment may be enacted. Although great strides have been made, under-diagnosis and under-treatment remain major hurdles. F1000 Research Limited 2019-01-14 /pmc/articles/PMC6338244/ /pubmed/30687501 http://dx.doi.org/10.12688/f1000research.15892.1 Text en Copyright: © 2019 Terrault NA http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Terrault, Norah A
Hepatitis C elimination: challenges with under-diagnosis and under-treatment
title Hepatitis C elimination: challenges with under-diagnosis and under-treatment
title_full Hepatitis C elimination: challenges with under-diagnosis and under-treatment
title_fullStr Hepatitis C elimination: challenges with under-diagnosis and under-treatment
title_full_unstemmed Hepatitis C elimination: challenges with under-diagnosis and under-treatment
title_short Hepatitis C elimination: challenges with under-diagnosis and under-treatment
title_sort hepatitis c elimination: challenges with under-diagnosis and under-treatment
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6338244/
https://www.ncbi.nlm.nih.gov/pubmed/30687501
http://dx.doi.org/10.12688/f1000research.15892.1
work_keys_str_mv AT terraultnoraha hepatitisceliminationchallengeswithunderdiagnosisandundertreatment